Back
Biomarin Pharmaceutical Vs. Quantum Industry Stock Comparison
Buy
58
BMRN
Biomarin Pharmaceutical
Last Price:
$66.21
Seasonality Move:
9.08%
Buy
56
QMCO
Quantum
Last Price:
$56.76
Seasonality Move:
5.03%
Buy
58
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $65.73. The Score for BMRN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $65.73Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
QMCO Stock Price Chart
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 48.21 | Sell |
Chaikin Money Flow: | -28579 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.97 - 66.75) | Sell |
Bollinger Bands (100): | (63.25 - 82.77) | Sell |
QMCO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 13.22 | Buy |
Relative Strength Index (14 RSI): | 61.48 | Buy |
Chaikin Money Flow: | -1212535 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.55 - 49.73) | Buy |
Bollinger Bands (100): | (-4.28 - 25.68) | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.09 | Sell |
20-day SMA: | 66.01 | Sell |
50-day SMA: | 66.22 | Sell |
200-day SMA: | 78.35 | Sell |
8-day EMA: | 66.07 | Sell |
20-day EMA: | 65.98 | Sell |
50-day EMA: | 67.34 | Sell |
200-day EMA: | 76.4 | Sell |
QMCO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.51 | Buy |
20-day SMA: | 33.96 | Buy |
50-day SMA: | 17.58 | Buy |
200-day SMA: | 10.03 | Buy |
8-day EMA: | 53.35 | Buy |
20-day EMA: | 39.27 | Buy |
50-day EMA: | 24 | Buy |
200-day EMA: | 12.53 | Buy |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $0.99 per share.
Quantum Earnings Growth & QMCO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.82 per share, and an increase next year of $2.64 per share.
Biomarin Pharmaceutical Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Quantum Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |